Company Overview and News

2
Rimfire Pacific strengthens team with appointment of business development manager

2018-08-15 proactiveinvestors.com.au
Rimfire Pacific Mining NL (ASX:RIM) has strengthened its resource industry experience and skills base by appointing Craig Riley as business development manager.
RIM NUS RTPPF RIO RIO RIO RTNTF NUSMF

0
Rimfire Pacific Mining will further examine gold potential of Fifield project

2018-07-31 proactiveinvestors.com.au
Rimfire Pacific Mining NL (ASX:RIM) will carry out further exploration in the next two months aimed at advancing the gold potential of the Southern area of its Fifield project in Central West NSW.
RIM

0
Rimfire Pacific Mining reveals potential for large-scale gold mineralisation at Fifield

2018-07-03 proactiveinvestors.com.au
Rimfire Pacific Mining NL’s (ASX:RIM) fieldwork in the Southern area of its Fifield project has highlighted the potential for large scale gold mineralisation.
RIM

0
Rimfire Pacific adds scandium to battery metals mix at Avondale prospect

2018-05-03 proactiveinvestors.com.au
Rimfire Pacific Mining NL (ASX:RIM) has confirmed cobalt and nickel mineralisation in drilling at the Avondale prospect of its Fifield project with scandium added to the mix.
RIM AUZ CLQ AMSLF

22
Rimfire Pacific Mining NL’s drilling confirms cobalt-nickel potential at Tout East

2018-05-02 proactiveinvestors.com.au
Rimfire Pacific Mining NL (ASX:RIM) has confirmed encouraging cobalt-nickel-scandium results from drilling at the Tout East prospect within its Fifield project in New South Wales.
RIM AUZ CLQ NGD NGDAF AMSLF NGD

2
Rimfire Pacific Mining looking for Lake Cowal style gold potential

2018-03-21 proactiveinvestors.com.au
Rimfire Pacific Mining NL (ASX:RIM) will complete field investigations for Lake Cowal style gold mineralisation over the southern portion of its Fifield Project in New South Wales.
RIM EVN CAHPF

0
Rimfire Pacific Mining receives encouraging early stage drill results from Fifield project

2018-03-19 proactiveinvestors.com.au
Rimfire Pacific Mining NL (ASX:RIM) has provided an update on results and progress of first pass drilling programs on the Northern View and Tout East prospects within its Fifield Project.
RIM

Related Articles

REPH: Recro Pharma Analysis and Research Report

23h - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

23h - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...